Cargando…
Mutations in epidermal growth factor receptor and K-ras in Chinese patients with colorectal cancer
BACKGROUND: Mutations of EGFR and K-ras are biomarkers for predicting the efficacy of targeting agents in non-small-cell lung cancer (NSCLC) and colorectal cancer (CRC). Data on the gene mutation status of EGFR and K-ras in Chinese patients with CRC are limited. METHODS: EGFR mutations in exon 18-21...
Autores principales: | Yunxia, Zuo, Jun, Cao, Guanshan, Zhu, Yachao, Lu, Xueke, Zhou, Jin, Li |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848222/ https://www.ncbi.nlm.nih.gov/pubmed/20184776 http://dx.doi.org/10.1186/1471-2350-11-34 |
Ejemplares similares
-
Mutations in epidermal growth factor receptor and K-ras in Chinese patients with colorectal cancer
por: Yunxia, Zuo, et al.
Publicado: (2010) -
A Modified Extraction Method of Circulating Free DNA for Epidermal Growth Factor Receptor Mutation Analysis
por: Yuan, Haihua, et al.
Publicado: (2012) -
Comparison of different methods for detecting epidermal growth factor receptor mutations in peripheral blood and tumor tissue of non-small cell lung cancer as a predictor of response to gefitinib
por: Xu, Fei, et al.
Publicado: (2012) -
Detection of K-ras Mutations in Predicting Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase (EGFR-TK) Inhibitor in Patients with Metastatic Colorectal Cancer
por: Li, Ze, et al.
Publicado: (2015) -
Discordance of Mutation Statuses of Epidermal Growth Factor Receptor and K-ras between Primary Adenocarcinoma of Lung and Brain Metastasis
por: Rau, Kun-Ming, et al.
Publicado: (2016)